Cognition Therapeutics Inc (NASDAQ: CGTX) on Tuesday, plunged -4.00% from the previous trading day, before settling in for the closing price of $1.75. Within the past 52 weeks, CGTX’s price has moved between $0.22 and $3.83.
During the last 5-year period, the sales drop of Healthcare Sector giant was -16.44%. The company achieved an average annual earnings per share of 54.65%. With a float of $80.15 million, this company’s outstanding shares have now reached $88.27 million.
Cognition Therapeutics Inc (CGTX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cognition Therapeutics Inc is 9.20%, while institutional ownership is 17.42%. The most recent insider transaction that took place on Jan 31 ’25, was worth 30,001. In this transaction CEO & President of this company bought 38,851 shares at a rate of $0.77, taking the stock ownership to the 38,851 shares.
Cognition Therapeutics Inc (CGTX) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.17 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.15) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to -16.44% drop over the previous five years of trading.
Cognition Therapeutics Inc (NASDAQ: CGTX) Trading Performance Indicators
Cognition Therapeutics Inc (CGTX) is currently performing well based on its current performance indicators. A quick ratio of 6.44 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.47, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.34 in one year’s time.
Technical Analysis of Cognition Therapeutics Inc (CGTX)
Looking closely at Cognition Therapeutics Inc (NASDAQ: CGTX), its last 5-days average volume was 1.03 million, which is a drop from its year-to-date volume of 4.09 million. As of the previous 9 days, the stock’s Stochastic %D was 75.11%.
During the past 100 days, Cognition Therapeutics Inc’s (CGTX) raw stochastic average was set at 34.34%, which indicates a significant decrease from 74.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1298 in the past 14 days, which was lower than the 0.1974 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6516, while its 200-day Moving Average is $1.0025. However, in the short run, Cognition Therapeutics Inc’s stock first resistance to watch stands at $1.7267. Second resistance stands at $1.7733. The third major resistance level sits at $1.7967. If the price goes on to break the first support level at $1.6567, it is likely to go to the next support level at $1.6333. Should the price break the second support level, the third support level stands at $1.5867.
Cognition Therapeutics Inc (NASDAQ: CGTX) Key Stats
Market capitalization of the company is 148.30 million based on 88,274K outstanding shares. Right now, sales total 0 K and income totals -33,970 K. The company made 0 K in profit during its latest quarter, and -4,930 K in sales during its previous quarter.
